GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (OTCPK:ABSCF) » Definitions » Valuation Rank

AB Science (AB Science) Valuation Rank


View and export this data going back to 2011. Start your Free Trial

What is AB Science Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

AB Science Valuation Rank Related Terms

Thank you for viewing the detailed overview of AB Science's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

AB Science (AB Science) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (OTCPK:ABSCF) » Definitions » Valuation Rank
Comparable Companies
XPAR:MLCOT XPAR:ALRPD XPAR:EAPI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
AB:France
Address
3, Avenue George V, Paris, FRA, 75008
Website
https://www.ab-science.com
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.